Literature DB >> 23480299

Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice.

Scott A Irwin1, Rosene D Pirrello, Jeremy M Hirst, Gary T Buckholz, Frank D Ferris.   

Abstract

Delirium is highly prevalent in those with serious or advanced medical illnesses. It is associated with many adverse consequences, including significant patient, family, and health care provider distress. This article suggests a novel approach to delirium assessment and management and provides useful, practical guidance for clinicians based on a complete review of the existing literature and the expert clinical opinion of the authors and their colleagues, derived from over a decade of collective bedside experience. Comprehensive assessment includes careful description of observed symptoms, signs, and behaviors; and an understanding of the patient's situation, including primary diagnosis, associated comorbidities, functional status, and prognosis. The importance of incorporating goals of care for the patient and family is discussed. The concepts of potential reversibility versus irreversible delirium and delirium subtype are proffered, with a description of how diagnostic and management strategies follow from these concepts. Pharmacological interventions that provide rapid, effective, and safe relief are presented. Employing both pharmacological and nonpharmacological interventions, including patient and family education, improves symptoms and relieves patient and family distress, whether the delirium is reversible or irreversible, hyperactive or hypoactive. All interventions can be provided in any setting of care, including patients' homes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23480299      PMCID: PMC3612281          DOI: 10.1089/jpm.2012.0319

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  118 in total

1.  Survival prediction of terminally ill cancer patients by clinical symptoms: development of a simple indicator.

Authors:  T Morita; J Tsunoda; S Inoue; S Chihara
Journal:  Jpn J Clin Oncol       Date:  1999-03       Impact factor: 3.019

2.  Sedative use in the last week of life and the implications for end-of-life decision making.

Authors:  Nigel Sykes; Andrew Thorns
Journal:  Arch Intern Med       Date:  2003-02-10

Review 3.  Propofol.

Authors:  Staffan Lundström; Robert Twycross; Mary Mihalyo; Andrew Wilcock
Journal:  J Pain Symptom Manage       Date:  2010-09       Impact factor: 3.612

4.  When nothing helps: propofol as sedative and antiemetic in palliative cancer care.

Authors:  Staffan Lundström; Ulla Zachrisson; Carl Johan Fürst
Journal:  J Pain Symptom Manage       Date:  2005-12       Impact factor: 3.612

Review 5.  Persistent delirium in older hospital patients: a systematic review of frequency and prognosis.

Authors:  Martin G Cole; Antonio Ciampi; Eric Belzile; Lihong Zhong
Journal:  Age Ageing       Date:  2008-11-18       Impact factor: 10.668

Review 6.  Evidence-based treatment of delirium in patients with cancer.

Authors:  William Breitbart; Yesne Alici
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

7.  The role of adherence on the effectiveness of nonpharmacologic interventions: evidence from the delirium prevention trial.

Authors:  Sharon K Inouye; Sidney T Bogardus; Christianna S Williams; Linda Leo-Summers; Joseph V Agostini
Journal:  Arch Intern Med       Date:  2003-04-28

Review 8.  The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients.

Authors:  S K Inouye
Journal:  Am J Med       Date:  1994-09       Impact factor: 4.965

9.  Terminal delirium: recommendations from bereaved families' experiences.

Authors:  Tatsuya Morita; Tatsuo Akechi; Masayuki Ikenaga; Shinichi Inoue; Hiroyuki Kohara; Tatsuhiro Matsubara; Naoki Matsuo; Miki Namba; Takuya Shinjo; Kazuhiko Tani; Yosuke Uchitomi
Journal:  J Pain Symptom Manage       Date:  2007-07-26       Impact factor: 3.612

10.  Delirium: phenomenologic and etiologic subtypes.

Authors:  C A Ross; C E Peyser; I Shapiro; M F Folstein
Journal:  Int Psychogeriatr       Date:  1991       Impact factor: 3.878

View more
  14 in total

Review 1.  Hospice in heart failure: why, when, and what then?

Authors:  Jeffrey L Spiess
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

Review 2.  Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.

Authors:  Shirley H Bush; Salmaan Kanji; José L Pereira; Daniel H J Davis; David C Currow; David Meagher; Kiran Rabheru; David Wright; Eduardo Bruera; Michael Hartwick; Pierre R Gagnon; Bruno Gagnon; William Breitbart; Laura Regnier; Peter G Lawlor
Journal:  J Pain Symptom Manage       Date:  2014-01-28       Impact factor: 3.612

3.  Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases.

Authors:  Alana Iglewicz; Katherine Morrison; Richard A Nelesen; Tingting Zhan; Boris Iglewicz; Nathan Fairman; Jeremy M Hirst; Scott A Irwin
Journal:  Psychosomatics       Date:  2014-06-05       Impact factor: 2.386

4.  Prevalence of Delirium in End-of-Life Palliative Care Patients: An Observational Study.

Authors:  Angela Recchia; Barbara Rizzi; Alessandra Favero; Alessandro Nobili; Luca Pasina
Journal:  Med Princ Pract       Date:  2022-01-17       Impact factor: 2.132

Review 5.  Delirium in patients with cancer: assessment, impact, mechanisms and management.

Authors:  Peter G Lawlor; Shirley H Bush
Journal:  Nat Rev Clin Oncol       Date:  2014-09-02       Impact factor: 66.675

6.  An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives.

Authors:  Peter G Lawlor; Daniel H J Davis; Mohammed Ansari; Annmarie Hosie; Salmaan Kanji; Franco Momoli; Shirley H Bush; Sharon Watanabe; David C Currow; Bruno Gagnon; Meera Agar; Eduardo Bruera; David J Meagher; Sophia E J A de Rooij; Dimitrios Adamis; Augusto Caraceni; Katie Marchington; David J Stewart
Journal:  J Pain Symptom Manage       Date:  2014-04-12       Impact factor: 3.612

7.  Drug therapy for delirium in terminally ill adults.

Authors:  Anne M Finucane; Louise Jones; Baptiste Leurent; Elizabeth L Sampson; Patrick Stone; Adrian Tookman; Bridget Candy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-21

8.  Development and validation of the Thai version of the 4 'A's Test for delirium screening in hospitalized elderly patients with acute medical illnesses.

Authors:  Sanchai Kuladee; Thanavadee Prachason
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-24       Impact factor: 2.570

9.  Delirium in the elderly: A systematic review of pharmacological and non-pharmacological treatments.

Authors:  Cecília Carboni Tardelli Cerveira; Cláudia Cristina Pupo; Sigrid De Sousa Dos Santos; José Eduardo Mourão Santos
Journal:  Dement Neuropsychol       Date:  2017 Jul-Sep

10.  Risk Factors and Antipsychotic Usage Patterns Associated With Terminal Delirium in a Veteran Long-Term Care Hospice Population.

Authors:  Emily M Ellsworth; Kevin J Bacigalupo; Kavita R Palla; Seema S Limaye; Margaret J Walkosz; Sandra T Szczecinski; Katie J Suda
Journal:  Fed Pract       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.